comparemela.com

Latest Breaking News On - Headlands technologies - Page 11 : comparemela.com

ProShares Ultra QQQ (NYSEARCA:QLD) Sets New 52-Week High at $95 38

ProShares Ultra QQQ (NYSEARCA:QLD – Get Free Report)’s share price reached a new 52-week high during trading on Tuesday . The stock traded as high as $95.38 and last traded at $95.29, with a volume of 1185178 shares trading hands. The stock had previously closed at $94.22. ProShares Ultra QQQ Price Performance The firm has […]

ProShares Short QQQ (NYSEARCA:PSQ) Reaches New 12-Month Low at $42 16

ProShares Short QQQ (NYSEARCA:PSQ – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $42.16 and last traded at $42.18, with a volume of 1610435 shares traded. The stock had previously closed at $42.42. ProShares Short QQQ Stock Performance The business has […]

Barometer Capital Management Inc Takes $2 Million Position in Bank of Montreal (NYSE:BMO)

Barometer Capital Management Inc. bought a new position in Bank of Montreal (NYSE:BMO – Free Report) (TSE:BMO) in the 4th quarter, Holdings Channel reports. The fund bought 20,240 shares of the bank’s stock, valued at approximately $2,003,000. Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. […]

Acadia Healthcare Company, Inc (NASDAQ:ACHC) is Avidity Partners Management LP s 5th Largest Position

Avidity Partners Management LP grew its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 61.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,156,692 shares of the company’s stock after buying an additional 441,692 shares during the quarter. Acadia Healthcare comprises 3.3% of Avidity Partners Management LP’s portfolio, making the […]

Avidity Partners Management LP Decreases Stake in Blueprint Medicines Co (NASDAQ:BPMC)

Avidity Partners Management LP lessened its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 18.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 615,000 shares of the biotechnology company’s stock after selling 136,600 shares during the quarter. Blueprint Medicines accounts for approximately 2.1% of Avidity […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.